• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Nat Commun

. 2026 Aug 12;17(1):9668.
doi: 10.1038/s41467-026-76680-4.

Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection​


Michelle N Vu 1 , R Elias Alvarado 1 2 , Dorothea R Morris 1 3 , Kumari G Lokugamage 1 4 5 , Yiyang Zhou 1 4 5 , Angelica L Morgan 1 4 5 , Yani P Ahearn 1 , Nicholas C Hazell 1 6 , Leah K Estes 1 , Alyssa M McLeland 1 , Craig Schindewolf 1 , Jessica A Plante 1 7 8 , William M Meyers 6 , Jordan T Murray 1 , Patricia A Crocquet-Valdes 6 , Scott C Weaver 1 7 8 , Mehul S Suthar 4 5 , David H Walker 6 9 , William K Russell 10 , Andrew L Routh 11 , Haitao Hu 1 6 9 12 , Kenneth S Plante 1 6 7 , Vineet D Menachery 13 14 15 16

Affiliations Expand


Abstract​


SARS-CoV-2 Omicron variants emerged in 2022 with >30 novel mutations in the spike alone. While most studies focus on receptor binding domain changes, mutations in the C-terminus of S1 (CTS1), adjacent to the furin cleavage site, have largely been ignored. Here, we examine three Omicron mutations in CTS1: H655Y, N679K, and P681H. Generating a SARS-CoV-2 triple mutant (YKH), we find that the mutant increases spike processing, consistent with prior reports for H655Y/P681H. In addition, the YKH mutant induces attenuated disease, but augments viral loads in male golden Syrian hamsters. Next, we generate a single N679K mutant, finding it reduces viral replication in Calu3 human respiratory cells and induces less disease in male golden Syrian hamsters. Mechanistically, the N679K mutant has increased spike processing but also reduces spike in purified virions; spike decreases are further exacerbated in infected Calu3 cell lysates. Importantly, exogenous spike expression reveals that N679K reduces overall spike protein in the context of the epidemic strain. Although a loss-of-function mutation, transmission competition demonstrates that N679K confers a replication advantage in the upper airway, potentially impacting transmissibility. Together, the data show that N679K reduces overall spike protein during Omicron infection, which has implications for infection, immunity, and transmission.
 
Back
Top Bottom